The R&D Discovery Platform drives identification, characterisation, and scale-up of novel biological actives — spanning bacteriology, entomology, and in vivo viral biopesticide production. State-of-the-art rearing of three economically significant insect species, validated LD50/LC50 bioassay expertise, and unique in-house UV stability testing and tensiometry give AgriViro R&D capabilities unavailable at most contract research organisations. 

The Production Platform converts validated candidates into commercial-volume biologicals through a proprietary submerged liquid fermentation scale-up pathway — benchtop to intermediate to industrial pilot — with minimal batch-to-batch variance.

Advanced formulation science produces Water Dispersible Granules (WDG), Suspension Concentrates (SC), and powders formulated to biorational standards, with specialised stabilisation of thermolabile biological actives for shelf-life integrity and field performance. 

Precision seed inoculation capabilities extends the platform into a high-value application: high-titer microbial coating integrating Plant Growth-Promoting Rhizobacteria (PGPR) for nutrient acquisition with antagonistic bacteria for robust, systemic biocontrol — dual-action biological performance from the point of planting.

AgriViro’s production infrastructure is platform-grade — designed for our own pipeline and for partnered, licensed, and contract biologicals programmes, including non-agricultural industrial microbiology applications. Strategically positioned in South Africa’s commercial heartland, AgriViro serves as the primary node for international firms seeking entry into the rapidly expanding African agricultural biologicals market.